CYP3A4 and acute myeloid leukemia: Because CYP3A4 inhibitor reversed the protective effects of BM niche, the authors proposed a combination of FLT3 TKIs with CYP3A4 inhibitors as a novel strategy to treat FLT3-ITD AML.